Luton, Bedfordshire, United Kingdom, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Pediatric Vaccines Market.
The Global Pediatric Vaccines Market is expected to reach USD 536.19 Million at a CAGR of 4.3% during the forecast period 2022-2029.
A lot of work has been put into creating and improving global health over the last two to three decades, especially in emerging and poor areas. The development of novel vaccinations and treatments to treat a variety of Pediatric medical diseases has been spearheaded by several international organizations, including the World Health Organization. The existence of several Pediatric vaccines Market is due to research and development efforts, which annually save the lives of close to 2-3 million children.
During the forecast period, it is predicted that demand for Pediatric vaccines Market would increase significantly as countries continue to prioritize upgrading the primary healthcare infrastructure. Currently, governments in both developed and developing regions place a rising emphasis on enhancing access to Pediatric immunizations, a development that is anticipated to enhance the global market for Pediatric vaccines Market over the assessment period. A large number of market participants have entered the present Pediatric vaccines Market, and they are leaning toward utilizing technological and scientific developments to manufacture Pediatric vaccinations that are efficient and effective.
Get Access Sample Copy of the Pediatric Vaccines Market Strategic Report:
North America Captures the Largest Market Share
North America is estimated to contribute the largest market share during the forecast timeframe. The largest proportion may be a result of extensive R&D investments, accessibility to state-of-the-art healthcare facilities, the existence of major market rivals, and the general public's high level of medical disease awareness. Asia-Pacific is predicted to grow at the highest CAGR throughout the projection period due to improved government policies to promote healthcare, particularly in developing economies like India and China.
Pediatric Vaccines Market - Competitive Landscape
Due to the presence of prominent oncology market rivals and their broad product selection of oncology pharmaceuticals, the competitive landscape in the lymphoma treatment market exhibits rather intense competition. Numerous significant industry players include Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd., Procaps, CAPTEK Softgel International Inc., Softcaps, Fuji Capsule Co., Ltd., Aenova Holding GmbH, Sirio Pharma Co., Ltd., Bahrain Pharma, Sanofi
Recent Development: -
- Merck and Sanofi’s First and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States
- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Catalent Biologics’ Paragon Gene Therapy unit, the leading viral vector development and manufacturing partner for gene therapies, today announced the closing of their previously announced arrangement.
| Report Attribute | Details |
| The revenue forecast in 2029 | 536.19 million |
| Growth Rate | CAGR of 4.3% from 2022 to 2029 |
| The base year for estimation | 2021 |
| Historical data | 2017-2021 |
| Forecast period | 2022 - 2029 |
| Quantitative units | Revenue in USD billion and CAGR from 2022 to 2029 |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered | By Application, By Distribution Channel |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; Japan; India; South Korea; Brazil |
| Key companies profiled | Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd., Procaps, CAPTEK Softgel International Inc., Softcaps, Fuji Capsule Co., Ltd., Aenova Holding GmbH, Sirio Pharma Co., Ltd., Bahrain Pharma, Sanofi |
Impact of COVID-19 on Pediatric Vaccines Market
It became vital to create vaccinations at an unprecedented tempo and scale for the specific pandemic after the SARS-CoV-2 virus emerged in December 2019 and its potential for worldwide dissemination to produce COVID-19 sickness was realized. As a result, the pandemic caused a drop in the global market for Pediatric vaccines Market in 2020 since the majority of healthcare professionals were preoccupied with managing COVID-19. The market for Pediatric vaccines Market has, nonetheless, projected significant growth through 2022. All thanks to the licensing of the COVID-19 vaccine for children in a select few western countries. Additionally, the publisher recognizes and quantifies the advantages that Pediatric vaccines Market and immunization programs have for both individuals and society in terms of health, economics, and social factors.
Browse Full Pediatric Vaccines Market Report: -
Key Market Segments: Pediatric Vaccines Market
Global Pediatric Vaccines Market: By Application
- Health Supplements
- Pharmaceutical
- Others
Global Pediatric Vaccines Market: By Distribution Channel
- Supermarket and Hypermarket
- Pharmacy and Drugstore
- Online Provider
Pediatric Vaccines Market Developments to Drive Progress
During the assessment period, recent developments and breakthroughs in next-generation rotavirus vaccines are anticipated to significantly increase the worldwide pediatric vaccines market. The introduction of innovative rotavirus vaccines has been crucial in reducing the incidence of hospital admissions for diarrhea among children five years old or younger. When included in national immunization programs, rotavirus has also proven to be a long-term, fully effective, and cost-effective treatment. Several rotavirus-related issues, such as diminished effectiveness and fading protection, are currently being addressed by those involved in the current pediatric vaccines, particularly among children in low- to middle-income countries. There have been several attempts to increase the rotavirus's efficacy, including new scheduling options, formulation changes, the creation of new oral vaccines, and the introduction of new vaccine types, such as injectable rotavirus. To combat the impending global threat of rotavirus sickness, industry participants in the existing market for pediatric vaccinations Market are currently engaging in efforts to produce new vaccines and other successful immunization strategies.
Browse More For Healthcare Market Reports
DT-Based Combined Vaccines
The expansion of government funding for healthcare organisations and the expanding availability of vaccines at reduced prices are driving the growth of the global DT-based combined vaccinations market. The market is benefiting from the increase of government immunization programs. The market for DT-Based Combined Vaccines is anticipated to increase as a result of medication development businesses investing more money to create highly efficient and affordable therapies that consumers want to purchase. On the other hand, significant financial investments in vaccine research and development may restrain the market growth.
Sterile Active Pharmaceutical Ingredients Market
A pharmaceutical ingredient is any combination of chemicals or material that is meant to be utilised in the creation of a medicine or therapeutic product. The active component in a drug is a chemical that is employed in the production of medicines. These elements are created to carry out pharmacological functions or have another direct impact on the diagnosis, treatment, mitigation, or cure of a disease. The way the body works and is built can also be directly impacted. As the study progresses, it is anticipated that the market for sterile active pharmaceutical ingredients would increase quickly due to the product's increasing importance.
